Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A study outlines the need for policies that enhance cancer patients' autonomy and information.

2.

Novel biomarker has potential for predicting and treating skin cancer metastasis

3.

PSMA PET: Prostate Cancer Staging Revolution Awaits RCT Data

4.

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

5.

For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot